Literature DB >> 11097720

Zollinger-Ellison Syndrome.

.   

Abstract

The first goal of therapy is the control of gastric acid hypersecretion using PPIs or high-dose H2R antagonists. The diagnosis of Multiple Endocrine Neoplasia (MEN I) should be established early in the disease. Localization of gastrinoma tumor should be performed using a combination of endoscopic ultrasonography (EUS), somatostatin receptor scintigraphy (SRS), and computerized tomography (CT), or Magnetic Resonance Imaging (MRI). Surgical resection in sporadic ZES should be performed to attempt cure of tumor. Surgery, hormonal, chemotherapy, embolization therapy or therapeutic OctreoScan should be considered in patients with metastatic tumor.

Entities:  

Year:  1999        PMID: 11097720      PMCID: PMC6721838          DOI: 10.1007/s11938-999-0059-5

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  41 in total

1.  Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high.

Authors:  D C Metz; J R Pisegna; V A Fishbeyn; R V Benya; K M Feigenbaum; P D Koviack; R T Jensen
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

Review 2.  Zollinger-Ellison syndrome.

Authors:  C L Berg; M M Wolfe
Journal:  Med Clin North Am       Date:  1991-07       Impact factor: 5.456

Review 3.  Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment.

Authors:  E Mozell; P Stenzel; E A Woltering; J Rösch; T M O'Dorisio
Journal:  Curr Probl Surg       Date:  1990-06       Impact factor: 1.909

Review 4.  Role of acid suppressants in patients with Zollinger-Ellison syndrome.

Authors:  P N Maton
Journal:  Aliment Pharmacol Ther       Date:  1991       Impact factor: 8.171

Review 5.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Testing for Helicobacter pylori in the diagnosis of Zollinger-Ellison syndrome.

Authors:  A Sonnenberg; W F Townsend
Journal:  Am J Gastroenterol       Date:  1991-05       Impact factor: 10.864

7.  Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.

Authors:  J R Pisegna; J A Norton; G G Slimak; D C Metz; P N Maton; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Adriamycin therapy for advanced insulinoma.

Authors:  R C Eastman; S E Come; G J Strewler; P Gorden; C R Kahn
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

9.  Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

Authors:  C G Moertel; M Lefkopoulo; S Lipsitz; R G Hahn; D Klaassen
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

10.  Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization.

Authors:  J R Pisegna; A de Weerth; K Huppi; S A Wank
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

View more
  2 in total

1.  Zollinger-Ellison Syndrome.

Authors:  Patrick D. Hung; Mitchell L. Schubert; Anastasios A. Mihas
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

2.  Biology and treatment of metastatic gastrointestinal neuroendocrine tumors.

Authors:  Jonathan R Strosberg; Aejaz Nasir; Pamela Hodul; Larry Kvols
Journal:  Gastrointest Cancer Res       Date:  2008-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.